Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 1.01 B1.02 B985 M1.02 B971 M1.02 B 4.01 B Research & development —————— — Operating income 573 M1.43 B1.24 B1.27 B989 M1.1 B 4.6 B Non-Operating Income, Total 31 M38 M106 M-1.72 B37 M67 M -1.51 B Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses 000-1.7 B00 -1.7 B Unusual income/expense 31 M38 M106 M-21 M37 M67 M 189 M Pretax income 578 M1.43 B1.32 B1.74 B1.03 B1.17 B 5.26 B Equity in earnings —————— — Taxes 97 M253 M223 M313 M155 M74 M 765 M Non-controlling/minority interest —————— — After tax other income/expense 3 M-13 M49 M-95 M1 M27 M -18 M Net income before discontinued operations 481 M1.17 B1.1 B1.43 B875 M1.09 B 4.5 B Discontinued operations —————— — Net income 481 M1.17 B1.1 B1.43 B875 M1.09 B 4.5 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 481 M1.17 B1.1 B1.43 B875 M1.09 B 4.5 B Basic earnings per share (Basic EPS) 3.338.177.699.956.167.7 31.5 Diluted earnings per share (Diluted EPS) 3.328.157.679.946.147.68 31.43 Average basic shares outstanding 144.6 M143.7 M143.1 M143.5 M142.1 M142.1 M — Diluted shares outstanding 144.9 M144 M143.5 M143.8 M142.5 M142.4 M — EBITDA 910 M1.54 B1.62 B1.68 B1.36 B1.46 B 6.12 B EBIT 573 M1.19 B1.24 B1.27 B989 M1.1 B 4.6 B Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 337 M350 M379 M406 M372 M367 M 1.52 B